Đại học Phan Châu Trinh
Đại học Phan Châu Trinh
Tuyển Sinh Đại Học
Tuyển sinh Đại học 2024
Kết nối với chúng tôi qua Zalo:

Liên hệ tuyển sinh

Gửi email cho chúng tôi:
Gọi hoặc Zalo cho chúng tôi:
Gửi hồ sơ về:
09 Nguyễn Gia Thiều, P. Điện Ngọc, TX. Điện Bàn, Quảng Nam
Theo dõi chúng tôi trên mạng xã hội
Theo dõi chúng tôi trên phương tiện truyền thông xã hội để không bỏ lỡ thông tin quan trọng về đăng ký, học bổng, cơ hội nghề nghiệp hấp dẫn và trải nghiệm đa dạng trong các hoạt động của chúng tôi.

Mallet Finger, ACL Injuries, Reducing Cardiovascular Mortality

Key Clinical Questions and Evidence-Based Answers from American Family Physician
View in a browser window »
AAFP
 
American Family Physician | Clinical Answers
 

What nonsurgical treatment is recommended for mallet finger?

mallet_finger

Mallet finger occurs when the distal interphalangeal joint (DIP) is forced to flex against resistance. In the absence of indications for referral, mallet finger (with or without an avulsion fracture) can be effectively treated with strict immobilization. The DIP joint should be splinted in full extension to slight hyperextension for eight weeks. Read the full article.

ADVERTISEMENT

ADVERTISEMENT

What steps can be taken to reduce ACL injuries?

Preventive strategies for anterior cruciate ligament (ACL) injury during athletics include lower extremity strengthening exercises and neuromuscular training focused on landing mechanics. Read the full article.

Are GLP-1 receptor agonists, SGLT-2 inhibitors, or DPP-4 inhibitors safe and effective at reducing cardiovascular mortality, all-cause mortality, and other cardiovascular outcomes (e.g., myocardial infarction, stroke, hospitalization from heart failure) in people with cardiovascular disease regardless of whether they have diabetes?

Glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular mortality, all-cause mortality, and stroke in people with cardiovascular disease. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors reduce cardiovascular mortality, all-cause mortality, and hospitalization from heart failure in people with cardiovascular disease. Dipeptidyl-peptidase-4
(DPP-4) inhibitors do not reduce mortality or cardiovascular outcomes in people with cardiovascular disease, and they increase the risk of pancreatitis. Read the full article.

 

❯ ❯ AFP Clinical Answers distills evidence-based answers to clinical questions from AFP content for use at the point of care. Visit our online collection for more.

 

Tip for Using AFP at the Point of Care

Are you looking for more Cochrane for Clinicians? All department collections are accessible from the AFP home page.

 

ADVERTISEMENT

Hurry—rates on student loans are going up. AAFP members get a limited-time rate discount of 0.25% (normally 0.125%) through 12/31/22. Refi your loans now with fixed rates as low as 4.49% APR 3.49% APR (with all discounts) for physicians with loan balances over $150K. Apply at SoFi.com/AAFP.

 

Read the latest issue of AFP. Earn 11 CME credits.

  • Adult Vaccination
  • Long COVID
  • Peripheral Edema
  • Editorials: Palliative Care in Children
  • Practice Guidelines: Osteoporosis
  • Cochrane for Clinicians: Discharge Planning
COVER
Read Online
Subscribe
Get the App
 
AAFP CAREER LINK
 

Family Medicine Physician - Pinon Family Practice - Farmington, NM

Family Medicine Physician - Benton County - Monroe, OR

Family Medicine Physician - Berkshire Health Systems - Pittsfield, MA

View more jobs

© 2022 by the American Academy of Family Physicians. All rights reserved. Acceptance of advertisements appearing in this email does not constitute endorsement by AFP or the AAFP.

American Academy of Family Physicians

11400 Tomahawk Creek Parkway | Leawood, KS 66211

(800) 274‑2237 | (913) 906‑6000

aafp@aafp.org | Visit our website

Facebook Twitter Blog YouTube
AMERICAN ACADEMY OF FAMILY PHYSICIANS - STRONG MEDICINE FOR AMERICA
 

Online access to content in new issues of American Family Physician is restricted to AAFP members and paid subscribers. Free full text is available for selected items. All content of each issue is made freely available about two years after publication. The bulk of the online archives is open to all. For access to all AFP content, you may want to subscribe to the journal or join the AAFP.

Received an AFP email forwarded from a colleague? Sign up to receive AFP emails directly.

If you no longer wish to receive AFP emails, you may unsubscribe or manage your email preferences. Your privacy is important to us. View our privacy policy.

Please do not reply to aafp@communications.aafp.org. If you have questions or need assistance, contact us at afptoc@aafp.org.